Your browser doesn't support javascript.
loading
Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional / Mortality within 30 days of receiving systemic chemotherapy at a regional oncology unit
Pulgar B, Dahiana; Yáñez B, Nicolás; Ortega G, Francisco.
Afiliação
  • Pulgar B, Dahiana; Universidad Católica del Maule. Facultad de Medicina. Centro de Oncología y radioterapia HRT. CL
  • Yáñez B, Nicolás; Universidad Católica del Maule. Facultad de Medicina. Centro de Oncología y radioterapia HRT. CL
  • Ortega G, Francisco; Universidad Católica del Maule. Facultad de Medicina. Centro de Oncología y radioterapia HRT. CL
Rev. méd. Chile ; 147(7): 887-890, jul. 2019. tab
Artigo em Espanhol | LILACS | ID: biblio-1058618
Biblioteca responsável: CL1.1
ABSTRACT

Background:

The use of systemic chemotherapy has survival and palliation benefits in oncological patients. Mortality at 30 days after the administration of systemic chemotherapy is considered as a quality and safety indicator of oncological patient care. The international mortality threshold is 5%, which is the figure used to compare institutions.

Aim:

To assess mortality at 30 days after the administration of ambulatory systemic chemotherapy in a regional referral center in adult cancer patients. Material and

Methods:

Retrospective observational study of patients receiving ambulatory systemic chemotherapy in the oncology service of a regional public hospital during 2018. The 30-day mortality rate was calculated. Demographic characteristics, baseline disease and the treatment received were recorded.

Results:

During the study period, 690 patients received ambulatory systemic chemotherapy. Chemotherapy was palliative in 76% of patients and 53% received a first line treatment. Seventeen (2.5%) died within 30 days of treatment administration. Nine deaths (52.9%) were definitely related to treatment and sepsis was the most frequent cause.

Conclusions:

Our mortality rates are similar to international data. This type of audit reviews local outcomes and identifies factors contributing to mortality aiming to improve standards of care.
Assuntos


Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: LILACS Assunto principal: Neoplasias / Antineoplásicos Tipo de estudo: Guia de prática clínica / Estudo observacional / Estudo prognóstico Limite: Adulto / Idoso / Feminino / Humanos / Masculino Idioma: Espanhol Revista: Rev. méd. Chile Assunto da revista: Medicina Ano de publicação: 2019 Tipo de documento: Artigo País de afiliação: Chile Instituição/País de afiliação: Universidad Católica del Maule/CL

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: LILACS Assunto principal: Neoplasias / Antineoplásicos Tipo de estudo: Guia de prática clínica / Estudo observacional / Estudo prognóstico Limite: Adulto / Idoso / Feminino / Humanos / Masculino Idioma: Espanhol Revista: Rev. méd. Chile Assunto da revista: Medicina Ano de publicação: 2019 Tipo de documento: Artigo País de afiliação: Chile Instituição/País de afiliação: Universidad Católica del Maule/CL
...